Elsevier

Nutrition Research

Volume 36, Issue 9, September 2016, Pages 889-898
Nutrition Research

Review Article
Probiotic supplementation can positively affect anxiety and depressive symptoms: a systematic review of randomized controlled trials

https://doi.org/10.1016/j.nutres.2016.06.009Get rights and content

Abstract

Gastrointestinal microbiota, consisting of microbial communities in the gastrointestinal tract, play an important role in digestive, metabolic, and immune functioning. Preclinical studies on rodents have linked behavioral and neurochemical changes in the central nervous system with deficits or alterations in these bacterial communities. Moreover, probiotic supplementation in rodents has been shown to markedly change behavior, with correlated changes in central neurochemistry. While such studies have documented behavioral and mood-related supplementation effects, the significance of these effects in humans, especially in relation to anxiety and depression symptoms, are relatively unknown. Thus, the purpose of this paper was to systematically evaluate current literature on the impact of probiotic supplementation on anxiety and depression symptoms in humans. To this end, multiple databases, including Medline, PsycINFO, PubMed, Scopus, and Web of Science were searched for randomized controlled trials published between January 1990 and January 2016. Search results led to a total of 10 randomized controlled trials (4 in clinically diagnosed and 6 in non-clinical samples) that provided limited support for the use of some probiotics in reducing human anxiety and depression. Despite methodological limitations of the included trials and the complex nature of gut-brain interactions, results suggest the detection of apparent psychological benefits from probiotic supplementation. Nevertheless a better understanding of developmental, modulatory, and metagenomic influences on the GI microbiota, specifically as they relate to mood and mental health, represent strong priorities for future research in this area.

Introduction

Microbial organisms in the human gastrointestinal tract, known as the gastrointestinal (GI) microbiota, play an important role in human health and well-being [1], [2], [3]. Composed largely of communities of bacteria, the GI microbiota exert a dynamic regulatory influence on the development and maintenance of digestive, metabolic, and immune functioning within hosts [1], [2], [3], [4], [5]. Moreover, early life deficits in certain bacterial communities or their later alterations (ie, dysbiosis) appear to influence human pathophysiology and development, particularly in inflammatory bowel disorders and colorectal cancer [4], [6]. The apparently extensive nature of microbial influences on host physiology has motivated some to view the GI microbiota as virtually an additional organ, with functions that merit more intensive examination [1]. The Human Microbiome Project is now making a consolidated effort to better characterize the diversity and relevance of these internally residing microorganisms [7].

Preclinical animal models, largely involving rodents and swine, have played an important role in shaping current understanding of the local and systemic immune-metabolic effects of the GI microbiota. Among these, are several recent rodent-based investigations that suggest roles for the GI microbiota in regulating key aspects of central nervous system (CNS) physiology, mood, and behavior [8], [9], [10], [11], [12], [13], [14], [15], [16], [17]. Specifically, these include demonstrations of altered neurochemical-behavioral profiles in germ-free (GF) mice. These GF studies point to: (a) regional differences in central gene expression, neurochemical concentrations, and turnover rates [8], [9], [10], [11], [12], [13], (b) exaggerated hypothalamic-pituitary-adrenal axis stress responses [8], [10], [11], [13], (c) reductions in anxious behaviors linked to changes in the GI microbiota, [9], [10], [11], and (d) greater social cognitive deficits [14], additionally related to the GI microbiota. These and other related investigations have shown that bacterial colonization early in life in GF mice can result in neurochemical modifications that influence stress and anxiety [8], [9], [11], [12]. Similar beneficial neurochemical and behavioral effects have also been reported in mice with normal GI microbiota after supplementation with probiotic bacteria, primarily the Bifidobacteria (eg, Bifidobacterium longum 1714, Bifidobacterium breve 1205) [15], [16] and Lactobacillus strains (eg, Lactobacillus rhamnosus JB-1) [17]. In parallel, swine-based models also highlight the critical role of the GI microbiota and bacterial supplementation in enhancing immune development and functioning [18], [19], [20], [21], [22], [23], [24], [25], [26]. These data include evidence of altered immune development and function in differentially raised (conventional vs isolator-raised) newborn [18], [19] and GF piglets [20], [21]. Moreover, probiotic supplementation in swine has been shown to positively impact GI microbiota, leading to: (a) increased production of short (eg, Butyrate) and branched chain fatty acids [22], (b) reduced concentrations of Clostridium and increased concentrations of Lactobacillus[22], [23], (c) improved immune functioning [22], [24], (d) greater antioxidant activity [25], and (e) reduced expression of proteins linked to the stress response [26] following supplementations with Lactobacillus fermentum I5007[22], [25], [26], Lactobacillus delbrueckii subsp. bulgaricus 2038[23], and Lactobacillus acidophilus[24].

Taken together, these observations highlight the importance of interrelationships between GI microbiota, CNS, and immune functioning in rodents and swine [8], [9], [11], [12], [26]. However, questions remain about the effectiveness of probiotic supplementation in improving human mental health, specifically in relation to anxiety and depressive symptomatology. Given that probiotic supplementation in humans has previously been linked to improved gastrointestinal, immune, and cardiovascular health [27], [28], [29], the primary objective of this review is to systematically evaluate findings from published randomized controlled trials (RCTs), evaluating the effects of probiotic supplementation on depressive and anxiety symptoms in healthy and clinically diagnosed patients. Specifically, we evaluated the hypothesis that probiotic supplementation in humans would result in reduced depressive and anxiety symptoms, an important question with translational implications for psychiatric research.

Section snippets

Approach: search strategy and inclusion criteria

A systematic literature search was carried out using MEDLINE, PsycINFO, PubMed, Scopus, and Web of Science databases for the period of January 1990 to January 2016. Search terms included probiotic* OR bacteria OR bifidobacterium OR lactobacillus AND depression* OR anxiety* OR mental health (see Appendix A for the exemplar MEDLINE search strategy). These searches were further supplemented by reviewing bibliographies of the trials selected for inclusion to identify additional studies. Studies

Study and participant characteristics

Search results, as shown in Fig. 1, led to a total of 158 citations across MEDLINE (n = 45), PsycINFO (n = 7), PubMed (n = 37), Scopus (n = 34), and Web of Science (n = 35) databases, with 5 additional citations identified by manual search (see Supplementary data for MEDLINE search strategy) [33], [34], [35], [36], [37]. After removal of duplicate citations (n = 47), of the remaining 111 citations, 91 were excluded based on the review of titles and abstracts, leaving 20 citations for further

Discussion

The health benefits of some fermented foods and symbiotic human-bacterial interactions have long been acknowledged [43], [44]. But only recently has there been a focus on better understanding their underlying mechanisms and the broader physical and mental health implications. Although swine-based models have been extensively employed to better understand the contributions of GI microbiota to immune development and function [18], [19], [20], [21], [22], [23], [24], [25], [26], rodent-based

Conclusions and future directions

In summary, despite limitations and/or inconsistencies in current findings, it appears that probiotic supplementation had a positive impact on reducing anxiety and depressive symptoms in several studies. These current findings must be regarded as tentative until future trials address the intricacies of GI microbiota-GBA-CNS interactions, particularly in relation to specific (probiotic) strains, mediating biochemical pathways, and activated neuroanatomy (Fig. 2). To this end, (a) an extension of

Acknowledgments

Authors would like to thank Vina Mohabir for her expertise in the design of Fig. 2. Authors report no conflicts of interests. Meysam Pirbaglou, Paul Ritvo, and Joel Katz conceived of the idea. Meysam Pirbaglou and Mehras Motamed performed database searches, evidence summaries, and drafting of the manuscript. Paul Ritvo, Joel Katz, Russell de Souza, and Jennifer Stearns provided critical commentary and revision of the manuscript.

References (73)

  • P Marteau et al.

    Basic aspects and pharmacology of probiotics: an overview of pharmacokinetics, mechanisms of action and side-effects

    Best Pract Res Clin Gastroenterol

    (2003)
  • H Szajewska et al.

    Recommendations on probiotics in allergy prevention should not be based on pooling data from different strains

    J Allergy Clin Immunol

    (2015)
  • SM Donovan et al.

    Noninvasive molecular fingerprinting of host-microbiome interactions in neonates

    FEBS Lett

    (2014)
  • E Vaghef-Mehrabany et al.

    Probiotic supplementation improves inflammatory status in patients with rheumatoid arthritis

    Nutrition

    (2014)
  • AM O’Hara et al.

    The gut flora as a forgotten organ

    EMBO Rep

    (2006)
  • CL Maynard et al.

    Reciprocal interactions of the intestinal microbiota and immune system

    Nature

    (2012)
  • LM Bustos Fernandez et al.

    Intestinal microbiota: its role in digestive diseases

    J Clin Gastroenterol

    (2014)
  • P Louis et al.

    The gut microbiota, bacterial metabolites and colorectal cancer

    Nat Rev Microbiol

    (2014)
  • PJ Turnbaugh et al.

    The human microbiome project: exploring the microbial part of ourselves in a changing world

    Nature

    (2007)
  • N Sudo et al.

    Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice

    J Physiol

    (2004)
  • R Diaz Heijtz et al.

    Normal gut microbiota modulates brain development and behavior

    Proc Natl Acad Sci

    (2011)
  • KM Neufeld et al.

    Reduced anxiety-like behavior and central neurochemical change in germ-free mice

    Neurogastroenterol Motil

    (2011)
  • G Clarke et al.

    The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner

    Mol Psychiatry

    (2013)
  • P Bercik et al.

    The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice

    Gastroenterology

    (2011)
  • L Desbonnet et al.

    Microbiota is essential for social development in the mouse

    Mol Psychiatry

    (2014)
  • HM Savignac et al.

    Bifidobacteria exert strain-specific effects on stress-related behavior and physiology in BALB/c mice

    Neurogastroenterol Motil

    (2014)
  • JA Bravo et al.

    Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve

    Proc Natl Acad Sci

    (2011)
  • IE Mulder et al.

    Restricting microbial exposure in early life negates the immune benefits associated with gut colonization in environments of high microbial diversity

    PLoS One

    (2011)
  • MC Lewis et al.

    Direct experimental evidence that early-life farm environment influences regulation of immune responses

    Pediatr Allergy Immunol

    (2012)
  • JE Butler et al.

    Antibody repertoire development in fetal and neonatal piglets. VIII. Colonization is required for newborn piglets to make serum antibodies to T-dependent and type 2 T-independent antigens

    J Immunol

    (2002)
  • H Liu et al.

    Oral administration of Lactobacillus fermentum I5007 favors intestinal development and alters the intestinal microbiota in formula-fed piglets

    J Agric Food Chem

    (2014)
  • Y Ohashi et al.

    Stimulation of indigenous lactobacilli by fermented milk prepared with probiotic bacterium, Lactobacillus delbrueckii subsp. bulgaricus strain 2038, in the pigs

    J Nutr Sci Vitaminol

    (2007)
  • J Qiao et al.

    Effects of Lactobacillus acidophilus dietary supplementation on the performance, intestinal barrier function, rectal microflora and serum immune function in weaned piglets challenged with Escherichia coli lipopolysaccharide

    Antonie Van Leeuwenhoek

    (2015)
  • AN Wang et al.

    Dietary supplementation with Lactobacillus fermentum I5007 improves the anti-oxidative activity of weanling piglets challenged with diquat

    J Appl Microbiol

    (2013)
  • AP Hungin et al.

    Systematic review: probiotics in the management of lower gastrointestinal symptoms in clinical practice – an evidence-based international guide

    Aliment Pharmacol Ther

    (2013)
  • P Gourbeyre et al.

    Probiotics, prebiotics, and synbiotics: impact on the gut immune system and allergic reactions

    J Leukoc Biol

    (2011)
  • Cited by (191)

    • Prospects of using biologically active substances to prevent depression

      2023, Nutrition Science, Marketing Nutrition, Health Claims, and Public Policy
    View all citing articles on Scopus
    View full text